Dissemination of two international linezolid-resistant Staphylococcus epidermidis clones in Greek hospitals.
Liakopoulos
A
A
Spiliopoulou
I
I
Damani
A
A
Kanellopoulou
M
M
Schoina
S
S
Papafragas
E
E
Marangos
M
M
Fligou
F
F
Zakynthinos
E
E
Makris
D
D
Protonotariou
E
E
Tsiapara
F
F
Filos
K
K
Diza
E
E
Anastassiou
E D
ED
Petinaki
E
E
D000081:Acetamides / Q000494:pharmacology*; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001426:Bacterial Proteins / Q000235:genetics; D015373:Bacterial Typing Techniques; D016000:Cluster Analysis; D003428:Cross Infection / Q000453:epidemiology* / Q000382:microbiology; D016172:DNA Fingerprinting; D024881:Drug Resistance, Bacterial; D005838:Genotype; D006115:Greece / Q000453:epidemiology; D006761:Hospitals; D006801:Humans; D000069349:Linezolid; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D020125:Mutation, Missense; D023303:Oxazolidinones / Q000494:pharmacology*; D017354:Point Mutation; D017422:Sequence Analysis, DNA; D013203:Staphylococcal Infections / Q000453:epidemiology* / Q000382:microbiology; D013212:Staphylococcus epidermidis / Q000145:classification* / Q000187:drug effects* / Q000302:isolation & purification; D055815:Young Adult
D000081:Acetamides; D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D023303:Oxazolidinones; D000069349:Linezolid